-
1 Comment
Target Capital Inc is currently in a long term uptrend where the price is trading 6.8% above its 200 day moving average.
From a valuation standpoint, the stock is 89.4% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 2.9.
Based on the above factors, Target Capital Inc gets an overall score of 2/5.
| Industry | Asset Management |
|---|---|
| Sector | Financial Services |
| ISIN | CA8761291076 |
| CurrencyCode | CAD |
| Exchange | V |
| PE Ratio | None |
|---|---|
| Market Cap | 2M |
| Dividend Yield | 0.0% |
| Target Price | None |
| Beta | 1.99 |
Target Capital Inc. is a private equity and venture capital firm specializing in acquisitions, startups, early stage and buyout companies. It owns interests in future commissions on claims processed through the Olympia Trust Health Plan. It invests in listed public companies, trailer fee rights, notes receivable, reporting issuers, and controlled private companies. The firm also invests in land development corporations. It seeks to invest in medical and recreational cannabis industry, and in businesses offering from cultivators to ancillary supportive products and services. It prefers to invest in Canada, Europe and United States. It prefers to invest in companies that generate 10x ROI Within 3 Years. It prefers to take majority stake. It prefers to exit through acquisition. Target Capital Inc. was incorporated in 1993 and is headquartered in Calgary, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TCI.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
